Emergent BioSolutions announces brincidofovir trial in Africa
Emergent BioSolutions (EBS) announced that brincidofovir will be included in a clinical trial conducted and sponsored by Panther, under the ...
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
PANTHER to conduct clinical trial under the leadership of Africa Centres for Disease Control and PreventionGAITHERSBURG, Md., Nov. 06, 2024 ...
Morningstar6d
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
Nov. 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that brincidofovir (brand name TEMBEXA®) will be included in a clinical trial conducted and sponsored by ...
AllAfrica.com1d
Africa: Smallpox Drug in Clinical Trials for Treating Mpox in Africa
Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...
Seeking Alpha on MSN5d
Emergent Biosolutions stock jumps 14% post-market on guidance raise
Emergent Biosolutions (EBS) stock rose 14% post-market after the company raised the lower end of its revenue guidance range ...
AllAfrica.com4d
Continental Health Body Launches Pan-African Study On Mpox
The Africa Centre Disease Control (CDC), with global health partners, has announced the launch of a "pivotal" clinical trial ...
Seeking Alpha5d
Emergent Biosolutions stock jumps 14% post-market on guidance raise
Emergent Biosolutions (NYSE:EBS) stock rose 14% post-market Wednesday after the company raised the lower end of its revenue guidance range and announced a study for its drug brincidofovir in the ...